Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of a randomized phase 2 trial.
about
Oral antiplatelet therapy for acute ischaemic strokeGlycoprotein IIb-IIIa inhibitors for acute ischaemic strokeAntiplatelet therapy for acute ischaemic strokeGlycoprotein IIb-IIIa inhibitors for acute ischaemic strokeWhat's new in stroke prevention and treatmentNew modalities and aspects of antiplatelet therapy for stroke preventionRole of abciximab in the treatment of coronary artery diseaseIntra-arterial versus intra-venous thrombolysis within and after the first 3 hours of stroke onsetRecanalization therapies in acute ischemic stroke: pharmacological agents, devices, and combinations.High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a randomised, double-blind, phase 3, placebo-controlled trial.Recommendations and treatment strategies for the management of acute ischemic stroke.Plasma fibrinolysis inhibitor levels in acute stroke patients with thrombolysis failure.Predicting final extent of ischemic infarction using artificial neural network analysis of multi-parametric MRI in patients with strokeBaseline NIH stroke scale responses estimate the probability of each particular stroke subtype.Defining clinically relevant cerebral hemorrhage after thrombolytic therapy for stroke: analysis of the National Institute of Neurological Disorders and Stroke tissue-type plasminogen activator trials.Fibrinolysis and Beyond: Bridging the Gap between Local and Systemic Clot Removal.Quantification of errors in ordinal outcome scales using shannon entropy: effect on sample size calculations.The GPVI-Fc fusion protein Revacept improves cerebral infarct volume and functional outcome in strokeAntiplatelet therapy in secondary stroke prevention--state of the artAntiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesIntravenous alteplase for acute ischaemic stroke.Tirofiban for the treatment of ischaemic stroke.Fibrinolytic treatment for acute ischaemic stroke.Platelet glycoprotein IIb/IIIa polymorphism HPA-3 b/b is associated with increased risk of ischemic stroke in patients under 60 years of age.Endovascular management of acute ischemic stroke: advances in patient and treatment selection.The quest for arterial recanalization in acute ischemic stroke-the past, present and the future.LOAD: a pilot study of the safety of loading of aspirin and clopidogrel in acute ischemic stroke and transient ischemic attack.Severity of leukoaraiosis correlates with clinical outcome after ischemic strokeSystematic reviews as a tool for planning and interpreting trials.Pharmacotherapy of cerebral ischemia.Prevention of ischemic stroke by vaccination: a missed challenge?Antithrombotic medication for stroke prevention.Intravenous thrombolysis in acute ischemic stroke: standard and potential future applications.Future trials of endovascular mechanical recanalisation therapy in acute ischemic stroke patients - a position paper endorsed by ESMINT and ESNR : part II: methodology of future trials.An Outcome Model for Intravenous rt-PA in Acute Ischemic Stroke.Anterior Circulation Acute Ischemic Stroke Associated with Atherosclerotic Lesions of the Cervical ICA: A Nosologic Entity Apart.Ischaemic Stroke and Transient Ischaemic Attack
P2860
Q24197866-8D81633C-17B8-4B8C-8189-5742877B4411Q24198012-7D06F55C-2740-4750-8605-7D07284077C3Q24242725-9F9845B9-04B6-4C84-9954-89CBA70CBAC2Q24243934-0E46DCC5-9583-4505-90C3-0B34AC808719Q28194923-C393735E-F1CE-4571-8F03-D398AE8A311FQ28195042-1B68AD07-E3A3-4A1C-B35D-C0CC3C2375FFQ28200177-C02313F9-61D4-4CFD-BDFE-55BC5302B385Q30470195-999146AF-FF8F-4ACC-ABFC-2F4F87E8882DQ30479878-DE42980B-D1D9-4247-8C5F-C426314577FEQ30572344-1C67C78B-4F8C-4566-BB5C-71DC7B7A097BQ31153077-E10B48FC-2002-4E23-88F6-EE19DE294F0BQ33790622-66D92176-1FDF-4A69-9929-42C03BADE9A9Q33996788-F03E0337-9B1B-4086-8F53-088801B9FF9FQ34037950-8371E7FA-C616-4F6A-A415-F23A47F94576Q34130790-C5764F79-66B5-47FB-8CE8-61F1F33F6121Q34603396-1F4D7C4E-BF16-4403-ABDD-E977EADEEBD8Q34826078-93D58E47-9FBF-4901-AD57-B87CF62007DDQ34917692-190FD822-6246-4E30-81D0-3A0441013EDFQ35216412-9F709873-6066-4B87-BC3A-591EB66F6D5BQ35752619-13379EC7-7866-4B1C-8B1D-7C4F8430517EQ36326254-089E74C2-3686-4856-B059-EEFC84B0B28CQ36349613-A3FEAA82-13E4-4534-977E-0F5D168D24F3Q36382572-053E35CE-9532-4FEF-8534-6DCA370C2998Q36577161-A6250551-7255-441B-8A9C-A871CE66C8CEQ36730655-9A0053F5-3AA5-479E-A5AC-344FC60BA494Q37017597-7B053FBA-C9B7-4AC4-968A-36BFD2624D21Q37145936-572C3F5F-3BE8-4D22-A5CB-7BA895079001Q37180499-E3BF9259-9D44-4303-9D87-73ED227641C9Q37399439-F14A63C2-AD38-4156-911F-C34CC5BEF6A3Q37514167-CEACAFD4-C2AA-477A-BD4A-86E74347772DQ37574013-B4D1B587-219B-40CE-81BD-95AD1781329AQ37611046-6605BA6E-C918-4F8C-B63D-F3A7948D4F88Q38225341-099A9400-6D0E-4F7E-AA73-36DC41C8164EQ39558458-2191594B-D5EE-4345-A75A-3CDBE27BE42DQ40523644-68EF2C89-8FC5-449E-89A1-A51BB28AFFDCQ47757290-AF4C7195-133F-49CF-A38B-33F6E4D0AA79Q57812836-35D8D447-4478-4E09-984B-DDA048ECB8F7
P2860
Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of a randomized phase 2 trial.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Emergency administration of ab ...... of a randomized phase 2 trial.
@en
Emergency administration of ab ...... of a randomized phase 2 trial.
@nl
type
label
Emergency administration of ab ...... of a randomized phase 2 trial.
@en
Emergency administration of ab ...... of a randomized phase 2 trial.
@nl
prefLabel
Emergency administration of ab ...... of a randomized phase 2 trial.
@en
Emergency administration of ab ...... of a randomized phase 2 trial.
@nl
P1433
P1476
Emergency administration of ab ...... of a randomized phase 2 trial.
@en
P2093
Abciximab Emergent Stroke Treatment Trial (AbESTT) Investigators
P304
P356
10.1161/01.STR.0000157668.39374.56
P407
P577
2005-02-24T00:00:00Z